BOKF vs BRK-B
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BOKF exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows strong recent earnings growth (YoY EPS +17%, Q/Q +11.7%) and beats earnings estimates in 3 of the last 4 quarters, supporting its current valuation above the Graham Number of $141.93. Profit margins and ROA are solid for the banking sector, but missing data on key leverage and liquidity ratios, along with insider selling, raise caution. The stock trades near analyst target ($134.30) with mixed technicals and low insider sentiment, warranting a cautious hold despite attractive yield and growth.
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
Compare Another Pair
Related Comparisons
BOKF vs BRK-B: Head-to-Head Comparison
This page compares BOK Financial Corporation (BOKF) and Berkshire Hathaway Inc. (BRK-B) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.